The Latest Breaking News from Disease

The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s (NASDAQ:BLUE) lead asset ZYNTEGLO (betibeglogene autotemcel) to treat the underlying genetic cause of beta‑thalassemia in adult and pediatric patients who require regular red blood cell (RBC) transfusions. Bluebird shares traded in a range of $6.13 to $8.18 on a day…

Dr. Walensky's proposed bureaucratic reshuffling is too timid.

Health professionals from Doomadgee have described the communication breakdowns and lack of resources in the remote Queensland Gulf town that lead to the death of three young women from a disease that was eradicated in non-Indigenous Australian communities in the 1950s and 60s.

‘Isn’t that strange?’ scientist says as he shares different disease caused by BA.5

From bowel cancer to Parkinson’s and dementia, the Edinburgh fringe is full of jokes about serious illness. What’s in it for the comedians – and their audiences?

The family of Jamie Tierney, three, have launched a Go Fund Me page and are raising as much cash as possible to help in his fight against terminal illness Duchenne Muscular Dystrophy.

Health officials are scrambling to stretch scarce doses of vaccine to slow the mounting monkeypox outbreak, but do older people already vaccinated as kids for the related but deadlier smallpox virus already have protection?

Planned burns at savannas across the Top End are polluting the air in Darwin, say a group of Australian researchers, raising concerns for people with asthma or lung disease.

Chris Stear turned 70 in June and celebrated the milestone by doing 70 push-ups non-stop on a Gold Coast beach. A few weeks later his health took a sudden turn, and an angiogram detected blockages in his coronary artery.